You are about to leave the Clinical Value website now.

Cancel

Hepatocellular carcinoma – the ‘silent killer’ | Part 2

Hepatocellular carcinoma %E2%80%93 the %E2%80%98silent killer Part 2

How did Taiwan halve the incidence of hepatocellular carcinoma (HCC) in a decade? HCC is the primary form of liver cancer, with 72% of cases diagnosed in Asia. Find out about the challenges people with HCC face, and what can be done to improve outcomes….

Hepatocellular carcinoma – the ‘silent killer’ | Part 1

A busy shopping street filled with locals and tourists, holding shopping bags in their hands.

Do you know what can cause hepatocellular carcinoma, the primary form of liver cancer? In Asia, contaminated food has historically been linked with the disease and hepatitis B and C continue to be a major risk factor. Find out more about these risk factors and others that are linked with liver cancer….

Liver cancer: the global impact

An overhead view of a crowd of people crossing the street at a crosswalk

Hepatocellular carcinoma numbers continue to rise globally, due to major risk factors such as Hepatitis B and C, and fatty liver disease. Hear Liver Patients International’s co-founder George Kalamitsis and liver cancer expert Dr Toh Han Chong discussing this major public health issue….

Breaking the link between chronic liver disease and liver cancer

Dan, a Hep C and liver cancer patient, sitting in his living room and laughing as he shares how treatment has given him hope.

Millions of people are living with chronic liver disease. Can the link between chronic liver disease and liver cancer be broken through partnership?…